← Back to browse

The Effects of a Modified Mediterranean Diet on Gut Microbiota and Chemotherapy Side Effects in Patients With Metastatic Colorectal Cancer Undergoing First-Line Chemotherapy With or Without Either Antiepidermal Growth Factor Receptor or Antivascular Endothelial Growth Factor Agent: Protocol for a Randomized Pilot Study in Italy

AuthorsSalvatore ArtaleOAFrancesca FilialiOAElena BerettaFrancesca ArosioOAFederica CazzanigaCarlo TersalviOAMichele SofiaPaola TagliabueOAPaola PozziOAAndrea ColomboClaudia CarboneLisa PietrogiovannaOAMagda VergaOAPaola NovaRossella CaloriOARossella RensoOASelene RotaOAStefania AglioneOAItalo ManfridaOAGiovanna FacendolaOAAlessandra TrojaniOAMaria Chiara DazzaniOASabrina BascianiOAMaria Grazia ValsecchiOAGiulia CapitoliOACinzia CocolaOAClarissa ConsolandiOA
Year2025
VenueJMIR Research Protocols

Background: The gut microbiota is attracting increasing interest as a factor possibly impacting colorectal cancer risk, therapy toxicity, and, as a consequence, patient’s quality of life. It has been observed that microbial imbalance in the gut and in cancer tissue is facilitated by a Western type of diet, rich in meat, sugars, and refined grains, while a Mediterranean diet, rich in low saturated fat and fibers, promotes gut eubiosis, and results in reduced risk of developing colorectal cancer. Specifically, a high fiber content diet has been associated with a reduced incidence of therapy related adverse events in patients with malignant melanoma.

Tags

JMIRStage 1 Manuscript
i